StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.14−0.10 (-4.46%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Biodexa Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Biodexa Pharmaceuticals's market cap was $1.32M on Nov 11, 2026, against $8.97M a year earlier. Over the last 5 years it ranged from $359.94K to $59.18B, with a median of $12.77M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.32M-70.7%
2025Dec 31, 2025$4.50M-12.1%
2024Dec 31, 2024$5.12M+286.3%
2023Dec 29, 2023$1.32M-100.0%
2022Dec 30, 2022$10.62B-82.1%
2021Dec 31, 2021$59.18B+21481.4%
2020Dec 31, 2020$274.23M+225.4%
2019Dec 31, 2019$84.27M-47.0%
2018Dec 31, 2018$159.08M-73.7%
2017Dec 29, 2017$604.22M-61.2%
2016Dec 30, 2016$1.56B–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?